Rebecca Cook
Faculty Member
Last active: 4/15/2019

Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth.

Morrison MM, Williams MM, Vaught DB, Hicks D, Lim J, McKernan C, Aurisicchio L, Ciliberto G, Simion C, Sweeney C, Cook RS
Oncogene. 2016 35 (9): 1143-52

PMID: 26148232 · PMCID: PMC4703573 · DOI:10.1038/onc.2015.169

MeSH Terms (17)

Animals Breast Neoplasms Cell Proliferation Disease-Free Survival Drug Resistance, Neoplasm Estradiol Estrogen Receptor alpha Estrogens Female Fulvestrant Gene Expression Regulation, Neoplastic Humans MCF-7 Cells Membrane Glycoproteins Mice Receptor, ErbB-3 Xenograft Model Antitumor Assays

Connections (1)

This publication is referenced by other Labnodes entities:

Links